Jump to Main Content

FDA Alerts

FDA Approves Givosiran for Acute Hepatic Porphyria

The Food and Drug Administration approved givosiran (GIVLAARI, Alnylam Pharmaceuticals, Inc.) for adults with acute hepatic porphyria (AHP).
Citations